Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2008 ASCO Annual Meeting. This abstract does not include a full text component.

Protein microarrays are one aspect of highly automated, large-scale biological screening technologies, the other is nucleic acid arrays. As DNA arrays reveal their origin in Southern blotting ...

New Haven, Conn. -- Researchers in the Department of Pathology at Yale University School of Medicine report that when using current pathology methods of biomarker detection, the concentration of ...

A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed. Screening with P85-Ab, ...

LUND, Sweden, Jan. 7, 2021 /PRNewswire/ -- Immunovia AB, ("Immunovia") a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today ...

The investment will support the expansion of CDI's technology platforms to service more customers. BALTIMORE, Jan. 9, 2023 /PRNewswire/ -- CDI Laboratories, Inc ("CDI Labs") announced today that it ...

SAN FRANCISCO and SUZHOU, China, May 19, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the ...

LUND, Sweden, May 27, 2021 /PRNewswire/ -- Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced that it ...